Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 178
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2491Acyl-CoA dehydrogenaseProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 4.7 +/- 2.5) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2492KetohexokinaseProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 4.7 +/- 3.7) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2493GRB2ProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 6.7 +/- 5.4) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2494Aldehyde dehydrogenaseProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 3.7 +/- 2.8) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2495Cathepsin DProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 3.5 +/- 3.3) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2496Guanidinoacetate N-methyltransferaseProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 5.3 +/- 8.6) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2497Catechol O-methyltransferaseProteinHumanDownregulated in HCC than non tumor (with mean ratio of nearly 3.2 +/- 3.8) DiagnosticHCC v/s non-tumor p < 0.05Tissue12481271
2498TGM2ProteinHumanUpregulated in HCC than non tumor DiagnosticHCC v/s normal p < 0.05Cell line, Tissue, Serum18646787
2510FGL2ProteinHumanUpregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2511MYADMProteinHumanUpregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2512GCProteinHumanUpregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2513OTCProteinHumanDownregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2514FGL2, GC, FLNA, FHL1, FBN2, TLN1ProteinHumanUpregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2515OTC, PEBP1, FABP1, CPS1, ARG1, EPHX1ProteinHumanDownregulated in HCC than non-tumor (with > 3 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue18715028
2516MT1GProteinHumanDownregulated in HCC than non-tumor (with 100 fold change) DiagnosticHCC v/s non-tumor p < 0.001Tissue16980951
2517FGGProteinHumanDownregulated in HCC than non-tumor (with 100 fold change) DiagnosticHCC v/s non-tumor p < 0.05Cell line, Tissue16980951
2518FGL1ProteinHumanDownregulated in HCC than non-tumor (with 100 fold change) DiagnosticHCC v/s non-tumor p < 0.05Cell line, Tissue16980951
2519Alpha-2-plasmin inhibitor, SERPINF2ProteinHumanDownregulated in HCC than non-tumor (with 100 fold change) DiagnosticHCC v/s non-tumor p < 0.05Cell line, Tissue16980951
2546HLA-DRProtein and RNAsHumanDownregulated in HCC with early IHR vs. HCC without recurrence (with Fiser ratio 1.56) PrognosticIntrahepatic recurrence v/s Non-recurrence p < 0.05Tissue15688398
2548PCNAProteinHumanUpregulated in HCC than non-HCC (avg ratio HCC to non-tumor 9.1 +/- 5.4) DiagnosticHCC v/s non-tumor p < 0.05Tissue15759316
2549Stathmin 1ProteinHumanUpregulated in HCC than non-HCC (avg ratio HCC to non-tumor 11.1 +/- 15.7) DiagnosticHCC v/s non-tumor p < 0.05Tissue15759316
2550FGGProteinHumanUpregulated in well-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2551Isocitrate dehydrogenase [NADP] (cytoplasmic), Fumarate hydratase (mitochondrial), Enoyl-CoA hydratase (mitochondrial), Betaine-homocysteine S-methyltransferase, Serotransferrin precursorProteinHumanDownregulated in well-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2552Aldo-keto reductase family 1 member B10, Alpha-1-antitrypsin precursorProteinHumanUpregulated in poorly-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2553Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6-ProteinHumanDownregulated in poorly-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2561HSP70ProteinHumanUpregulated in early HCC components Diagnostic and prognosticnodule-in-nodule-type HCCs and corresponding noncancerous liver tissues p< .001Tissue12500205
2564EFNA1Protein and RNAsHumanUpregulated in HCC Diagnostic and PrognosticHCC v/s non-tumor/normal; associated with the poor survival of patients p< 0.001Tissue and Seum19642143
2565EphA2Protein and RNAsHumanDownregulated in HCC Diagnostic and PrognosticHCC v/s non-tumor/normal; associated with the poor survival of patients p < 0.05Tissue and Seum19642143

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top